In preclinical cancer model studies of breast cancer, the upregulation of CCL2 expressed by tumor cells has been found to promote the recruitment of TAMs; moreover, VEGF-C and VEGF-D secreted by TAMs have been found to promote the lymphatic metastasis of tumor cells. This evidence concerns the gene VEGFD and neoplasm.